MedPath

Papaverine

Generic Name
Papaverine
Drug Type
Small Molecule
Chemical Formula
C20H21NO4
CAS Number
58-74-2
Unique Ingredient Identifier
DAA13NKG2Q

Overview

An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.

Background

An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.

Indication

For the treatment of impotence and vasospasms.

Associated Conditions

  • Vascular spasm
  • Visceral spasms

FDA Approved Products

Papaverine Hydrochloride
Manufacturer:Oryza Pharmaceuticals Inc.
Route:INTRAVENOUS
Strength:30 mg in 1 mL
Approved: 2021/01/26
NDC:72516-024
PAPAVERINE HYDROCHLORIDE
Manufacturer:BPI Labs LLC
Route:PARENTERAL, INTRAVENOUS, INTRAMUSCULAR
Strength:30 mg in 1 mL
Approved: 2023/04/26
NDC:54288-142
Papaverine Hydrochloride
Manufacturer:American Regent, Inc.
Route:INTRAVENOUS
Strength:30 mg in 1 mL
Approved: 2023/11/17
NDC:0517-4002
Papaverine Hydrochloride
Manufacturer:Nexus Pharamaceuticals Inc.
Route:INTRAVENOUS, INTRAMUSCULAR
Strength:30 mg in 1 mL
Approved: 2023/05/01
NDC:14789-121

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath